To investigate how SERT blockade alters tumor-infiltrating CD8 T cell compartment, we isolated CD45+ tumor-infiltrating immune cells from B6 mice bearing B16-OVA tumors treated with or without FLX and conducted a single-cell RNA sequencing (scRNA-seq) study (Figure 2A). This evidence concerns the gene SLC6A4 and neoplasm.